Literature DB >> 10841763

Novel insights into catalytic mechanism from a crystal structure of human topoisomerase I in complex with DNA.

M R Redinbo1, J J Champoux, W G Hol.   

Abstract

Human topoisomerase I helps to control the level of DNA supercoiling in cells and is vital for numerous DNA metabolic events, including replication, transcription, and recombination. The 2.6 A crystal structure of human topoisomerase I in noncovalent complex with a DNA duplex containing a cytosine at the -1 position of the scissile strand rather than the favored thymine is reported. The hydrogen bond between the O2 position of this -1 base and the epsilon-amino of the conserved Lys-532 residue, the only base-specific contact observed previously in the human topoisomerase I-DNA interaction, is maintained in this complex. Several unique features of this structure, however, have implications for the DNA-binding and active-site mechanisms of the enzyme. First, the ends of the DNA duplex were observed to shift by up to 5.4 A perpendicular to the DNA helical axis relative to structures reported previously, suggesting a novel degree of plasticity in the interaction between human topoisomerase I and its DNA substrate. Second, 12 additional residues at the NH(2) terminus of the protein (Trp-203-Gly-214) could be built in this structure, and they were found to pack against the putative hinge region implicated in the clamping of the enzyme around duplex DNA. Third, a water molecule was observed adjacent to the scissile phosphate and the active-site residues; the potential specific base character of this solvent molecule in the active-site mechanism of the enzyme is discussed. Fourth, the scissile phosphate group was found to be rotated by 75 degrees, bringing Lys-532 into hydrogen-bonding distance of one of the nonbridging phosphate oxygens. This orientation of the scissile phosphate group implicates Lys-532 as a fifth active-site residue, and also mimics the orientation observed for the 3'-phosphotyrosine linkage in the covalent human topoisomerase I-DNA complex structure. The implications of these structural features for the mechanism of the enzyme are discussed, including the potential requirement for a rotation of the scissile phosphate group during DNA strand cleavage and covalent attachment.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10841763     DOI: 10.1021/bi992690t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

1.  Structure and hydration of the DNA-human topoisomerase I covalent complex.

Authors:  G Chillemi; T Castrignanò; A Desideri
Journal:  Biophys J       Date:  2001-07       Impact factor: 4.033

2.  Protein concerted motions in the DNA-human topoisomerase I complex.

Authors:  Giovanni Chillemi; Paola Fiorani; Piero Benedetti; Alessandro Desideri
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

3.  Residues 190-210 of human topoisomerase I are required for enzyme activity in vivo but not in vitro.

Authors:  Morten O Christensen; Hans U Barthelmes; Fritz Boege; Christian Mielke
Journal:  Nucleic Acids Res       Date:  2003-12-15       Impact factor: 16.971

4.  Role of the linker domain and the 203-214 N-terminal residues in the human topoisomerase I DNA complex dynamics.

Authors:  G Chillemi; M Redinbo; A Bruselles; A Desideri
Journal:  Biophys J       Date:  2004-09-03       Impact factor: 4.033

Review 5.  Human DNA topoisomerase I: relaxation, roles, and damage control.

Authors:  John B Leppard; James J Champoux
Journal:  Chromosoma       Date:  2005-04-14       Impact factor: 4.316

Review 6.  Probing enzyme phosphoester interactions by combining mutagenesis and chemical modification of phosphate ester oxygens.

Authors:  James T Stivers; Rajesh Nagarajan
Journal:  Chem Rev       Date:  2006-08       Impact factor: 60.622

7.  Lipophilic peptides for gene delivery.

Authors:  Carla A H Prata; Xiao-Xiang Zhang; Dan Luo; Thomas J McIntosh; Philippe Barthelemy; Mark W Grinstaff
Journal:  Bioconjug Chem       Date:  2008-01-11       Impact factor: 4.774

8.  8-Oxoguanine rearranges the active site of human topoisomerase I.

Authors:  Diem-Thu Thieu Lesher; Yves Pommier; Lance Stewart; Matthew R Redinbo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-03       Impact factor: 11.205

9.  Structural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complex.

Authors:  Giordano Mancini; Ilda D'Annessa; Andrea Coletta; Nico Sanna; Giovanni Chillemi; Alessandro Desideri
Journal:  PLoS One       Date:  2010-06-03       Impact factor: 3.240

10.  Mechanistic studies of the modulation of cleavage activity of topoisomerase I by DNA adducts of mono- and bi-functional PtII complexes.

Authors:  Jaroslav Malina; Oldrich Vrana; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2009-07-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.